Search for: "PFIZER V TEVA PHARMACEUTICALS"
Results 61 - 80
of 183
Sort by Relevance
|
Sort by Date
13 Jul 2011, 3:04 am
Doubtful (FDA Law Blog) US: Joint citizen petition asks FDA for clarity on off-label use manufacturer-communications (FDA Law Blog) Products Allegra (Fexofenadine) – US: Sanofi settles with Actavis in Allegra suit (Patent Docs) Aloxi (Palonosetron) – US: Roche sues Teva, Sandoz, Dr Reddy over generic Aloxi (GenericsWeb) Amrix (Cyclobenzaprine) – US: CAFC changes course, denies stay of injunction of Mylan’s generic Amrix sales: In re Cyclobenzaprine… [read post]
6 Jul 2011, 2:21 am
Teva Pharms. [read post]
29 Jun 2011, 3:34 am
Mutual Pharmaceutical (Patently-O) (Patent Docs) Viagra (Sildenafil) – US: Pfizer fights to keep up Viagra patent (IP Osgoode) [read post]
22 Jun 2011, 4:09 am
Highlights this week included: US Supreme Court to revisit patentable subject matter eligibility of medical diagnostic methods: Mayo v Prometheus (Patently-O) (Patent Baristas) (PharmaPatents) (IPBiz) (Patent Law Practice Center) Baytril (Enrofloxacin) – US: In a rare move, District Court extends 30-month stay on FDA ANADA approval: Bayer Healthcare v Norbrook (FDA Law Blog) Europe seizure of generic drugs: Lilly settles with Indian generics (Generic… [read post]
15 Jun 2011, 4:56 am
(Patent Docs) Azilect (Rasagiline) – US: Patent infringement complaint filed in response to Para IV certification: Teva Neuroscience, Inc. et al. v. [read post]
2 Jun 2011, 12:46 pm
Pfizer, Inc., 153 S.W.3d 758, 761 (Ky. 2004) (dictum also extends rule to medical devices). [read post]
31 May 2011, 8:38 pm
Labs. v. [read post]
11 May 2011, 4:54 am
ARUP: Genetic testing patents found to be anticipated and in violation of Lilly written description requirement (Holman’s Biotech IP Blog) (Patent Docs) (Patently-O) US: FDA gets the ball rolling on biosimilar/interchangeable biological product user fee program; proposal gives a hat tip to PDUFA while acknowledging the nascent state of the industry (FDA Law Blog) (Patent Docs) Products Citalopram – UK Patents Court disapproving of EPO’s approach to assessment of novelty: Lundbeck… [read post]
21 Apr 2011, 1:36 pm
Teva Pharmaceuticals USA, Inc., 2007 WL 5787186 (S.D. [read post]
12 Apr 2011, 10:07 pm
Highlights this week included: Cosopt (Dorzolamide, Timolol) – UK: EWCA (Civ) rejects bid to revive patent covering Cosopt: Merck v Teva (IPKat) (The IP Factor) (EPLAW) (GenericsWeb) Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be monitored. [read post]
6 Apr 2011, 12:18 am
195/09 Synthon BV v Merz Pharma GmbH & Co KG (The SPC Blog) Amrix (Cyclobenzaprine) – US: Eurand files patent infringement complaint against Anchen in response to Para IV certification (Patent Docs) Asacol (Mesalamine) – US: NJ District Court punts in Asacol DJ action to trigger 180-day exclusivity forfeiture; Rules that subsequent ANDA applicant lacks standing: Medeva Pharma Suisse v Par Pharmaceuticals (FDA Law Blog) Cialis (Tadalafil) – Israel:… [read post]
29 Mar 2011, 9:19 pm
(Kluwer Patent Blog) Prezista (Darunavir) – US: Tibotec files patent infringement complaint against Teva in response to Para IV certification (Patent Docs) Provigil (Modafinil) – US: Apotex’s generic Provigil found not to infringe Cephalon patent (Patent Docs) Seasonique (Levonorgestrel, Ethinyl estradiol) – US: CAFC reversed summary judgment of nonobviousness in Duramed v Watson (Patent Docs) (IPBiz) Simcor (Niacin/Simvastatin) – US: Abbott files… [read post]
2 Feb 2011, 3:52 am
General Technical symposium to address access to medicines, patent information and freedom to operate (WIPO) Brazil: Brazilian Attorney General of the Union restricts ANVISA’s role in pharmaceutical patent review (PatentlyBIOtech) India: Protection of Plant Varieties and Farmers’ Rights Authority appoints new Chairperson (Spicy IP) Italy: Tribunale di Milano: Mere filing of application for marketing authorization of a generic drug does not constitute infringing activity: Eli… [read post]
25 Jan 2011, 10:58 pm
Cephalon (Patently-O) Seroquel (Quetiapine) – UK: Teva launches High Court action to revoke AstraZeneca’s European patent (IP Factor) Synagis – US: PDL BioPharma Synagis patent invalidated: Medimmune v PDL BioPharma (Patent Docs) Tarka (Trandolapril, Verapamil) – US: Glenmark loses jury verdict in DNJ over Tarka (IPBiz) Wechol (Colesevelam) – US: Watson confirms Welchol oral suspension patent challenge (SmartBrief) [read post]
19 Jan 2011, 2:00 am
– Health Care Reform Bill (Patent Baristas) US: Academic study supports longer data exclusivity term for conventional drugs (Patent Docs) US: PTO sued after denying ‘mildly tardy’ second interim PTE request: Genetics & IVF Institute v Kappos (FDA Law Blog) US: AMP v USPTO – Appellees’ brief (Patent Docs) Products Avodart (Dutasteride) – US: GlaxoSmithKline file patent infringement complaint against Anchen following Para IV certification… [read post]
29 Dec 2010, 2:57 am
Ferring Pharmaceuticals, Inc et al. [read post]
22 Dec 2010, 3:01 am
(Patent Docs) Yaz (Drospirenone, Ethinyl estradiol) – Bayer settles with Teva in multiple Yaz patent disputes: Bayer v Teva (Patent Docs) [read post]
10 Nov 2010, 1:11 am
Roche (Filewrapper) (Property, intangible) US: Senator Sanders letter to FDA: U.S. needs an ethical pathway for biological products (KEI) (FDA Law Blog) US: Daiichi Sankyo seeks review and correction of patent term adjustment calculation for patent relating to ‘nucleoside and oligonucleotide analogues’ (Patent Docs) US: CAFC in Abraxis v Navinta: remembering Stanford/Roche (IPBiz) Products Alimta (Pemetrexed) – US: Eli Lilly files patent infringement complaint against… [read post]
8 Nov 2010, 7:35 am
Teva Pharmaceuticals USA, Inc., C.A. [read post]
3 Nov 2010, 5:10 am
Teva Pharmaceuticals USA, Inc., 518 F.3d 1353 (Fed. [read post]
